Skip to main content

Fuchs' Dystrophy clinical trials at UCSF

2 research studies open to eligible people

Fuchs' dystrophy is when the eye's cornea swells, affecting vision. UCSF is conducting clinical trials to study the thickness of the cornea in affected patients. The studies compare different treatments to see how they change corneal thickness.

Showing trials for
  • Descemet Endothelial Thickness Comparison Trial I

    open to eligible people ages 18 years and up

    Descemet Endothelial Thickness Comparison Trial (DETECT) I is a multi-center, outcome assessor-masked, placebo-controlled clinical trial randomizing 160 patients in a 2x2 factorial design. The purpose of this study is to determine differences in…

    Palo Alto, California and other locations

  • Descemet Endothelial Thickness Comparison Trial II

    open to eligible people ages 18 years and up

    Descemet Endothelial Thickness Comparison Trial (DETECT) II is a multi-center, outcome assessor-masked, placebo-controlled clinical trial randomizing 60 patients with Fuchs endothelial dystrophy to DMEK versus Descemet Stripping Only (DSO) with…

    Palo Alto, California and other locations

Last updated: